drugset / Trial / NCT02943655
Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause
RandomizedParallel-groupOpen-labelTreatment
Summary
Abnormal uterine bleeding encompasses abnormalities in the regularity, duration of flow, frequency, and/or blood flow volume relative to normal menstruation. Of these menstrual abnormalities, heavy menstrual bleeding (HMB), defined objectively as a blood loss of 80 ml or more per menstrual cycle , which is unrelated to pregnancy or known pelvic or systemic disease.
Timeline
- Start
- 2017-11-01
- Primary completion
- 2020-10-10
- Completion
- 2021-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mefenamic acid | Small molecule | 500 mg | Oral |
| Comparator | medroxyprogesterone acetate | Other / unclassified | 5 mg | Oral |
| Comparator | microcept | Unknown | — | Oral |
Indications
No indication recorded.